ARKK vs OMCL
ARK Innovation ETF (ARKK) versus Omnicell Inc (OMCL) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
Omnicell Inc (OMCL) is a health information services company listed on NASDAQ.
ARKK does not have a complete income-statement cache yet.
Latest reported OMCL revenue for 2026-06-30 was $622.1M. Net income was $35.6M. OMCL currently screens at market cap $1.80B and trailing P/E 89.9.
ARKK currently screens at market cap $0. OMCL currently screens at market cap $1.80B and trailing P/E 89.9.
Not investment advice. Open the ARKK and OMCL stock pages for the full models.
Not investment advice.